| NCT04461366 |
Monopolar Radiofrequency Versus Pulsed Dye Laser for Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT04461366 |
Completed |
Cairo University |
2019-12-30 |
| NCT02058628 |
Comparison of the Efficacy and Safety of Clindamycin + Benzoyl Peroxide Formulation With Azelaic Acid Formulation in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02058628 |
Completed |
GlaxoSmithKline |
2014-09-08 |
| NCT03393494 |
Bioequivalence Study of Two Treatments in the Treatment of Acne Vulgaris on the Face |
https://ClinicalTrials.gov/show/NCT03393494 |
Completed |
Perrigo Company |
2018-09-30 |
| NCT03380845 |
Comparison of 1,550-nm Laser and Fractional Radiofrequency Microneedle for the Treatment of Acne Scars in Ethnic Skin |
https://ClinicalTrials.gov/show/NCT03380845 |
Completed |
Massachusetts General Hospital |
2018-10-30 |
| NCT03361345 |
Topical 5% Tranexamic Acid as a Treatment for Postinflammatory Hyperpigmentation Due to Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03361345 |
Recruiting |
Wayne State University |
2021-12-31 |
| NCT03341910 |
A Study to Assess the Safety and Local Tolerability of DFD-03 (Tazarotene) Lotion, 0.1% Compared to Tazorac® (Tazarotene) Cream, 0.1% in the Topical Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03341910 |
Completed |
Dr. Reddy’s Laboratories Limited |
2018-05-18 |
| NCT03334682 |
Randomized Double-blind Study on the Benefit of Spironolactone for Treating Acne of Adult Woman. |
https://ClinicalTrials.gov/show/NCT03334682 |
Recruiting |
Nantes University Hospital |
2021-12-31 |
| NCT03303170 |
Non-Significant Risk Study of Sebacia Microparticles in the Treatment of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03303170 |
Completed |
Sebacia, Inc. |
2018-04-10 |
| NCT03290027 |
A Study of the Safety and Efficacy of DFD-03 for the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03290027 |
Completed |
Dr. Reddy’s Laboratories Limited |
2018-04-19 |
| NCT03264287 |
Efficacy of Acupuncture Combined With Moving Cupping and Ear Point Tapping for Moderate and Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03264287 |
Recruiting |
Guang’anmen Hospital of China Academy of Chinese Medical Sciences |
2019-12-31 |
| NCT03178994 |
The Study of Efficacy and Safety of 2% Ketoconazole Cream in Thai Females With Mild Degree of Post - Adolescence Acne |
https://ClinicalTrials.gov/show/NCT03178994 |
Completed |
Chulalongkorn University |
2018-09-15 |
| NCT03170388 |
A Phase 2, Multicenter, Randomized, Double-Blind, Vehicle Controlled, Parallel-Group, Clinical Study in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03170388 |
Completed |
Bausch Health Americas, Inc. |
2019-04-23 |
| NCT03168334 |
Multi-center, Randomized, Double-blind, Vehicle-controlled Efficacy and Safety Study in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03168334 |
Completed |
Bausch Health Americas, Inc. |
2018-04-26 |
| NCT03168321 |
A Phase 3, Double-Blind 2 Arm Study in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03168321 |
Completed |
Bausch Health Americas, Inc. |
2018-03-16 |
| NCT03128723 |
A Study to Evaluate the Tolerance of an Acne Treatment in Sensitive Skin Subjects With Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03128723 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2017-06-08 |
| NCT03127956 |
A Long-term Safety Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03127956 |
Completed |
Dermira, Inc. |
2018-04-27 |
| NCT03124381 |
A Study to Evaluate the Efficacy and Tolerance of 2 Acne Treatment Regimens on Subjects With Mild to Moderate Acne |
https://ClinicalTrials.gov/show/NCT03124381 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2017-09-06 |
| NCT03073486 |
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03073486 |
Completed |
Dermira, Inc. |
2017-12-21 |
| NCT03057821 |
Propionibacterium Acnes in Shoulder Arthroplasty |
https://ClinicalTrials.gov/show/NCT03057821 |
Completed |
University of Utah |
2019-03-31 |
| NCT03034460 |
Efficacy and Safety of CD5024 1% in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03034460 |
Completed |
Galderma R&D |
2016-11-30 |
| NCT03028363 |
A Study of Olumacostat Glasaretil Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03028363 |
Completed |
Dermira, Inc. |
2017-11-28 |
| NCT03003247 |
Efficacy and Safety of IDP-120 Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03003247 |
Completed |
Bausch Health Americas, Inc. |
2016-08-31 |
| NCT02965456 |
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02965456 |
Completed |
Bausch Health Americas, Inc. |
2017-02-23 |
| NCT02959970 |
Safety and Efficacy Trial of ACZONE (Dapsone) Gel, 7.5% in 9 to 11 Year-Old Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02959970 |
Completed |
Almirall, S.A. |
2018-03-09 |
| NCT02946788 |
Open Label Photo-Documentation Study Of BPX-01 Minocycline Gel |
https://ClinicalTrials.gov/show/NCT02946788 |
Completed |
BioPharmX, Inc. |
2018-06-01 |
| NCT02944461 |
Efficacy and Safety of Aczone 7.5% Gel in the Treatment of Truncal Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02944461 |
Completed |
Derm Research, PLLC |
2017-09-30 |
| NCT02938494 |
Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02938494 |
Completed |
Bausch Health Americas, Inc. |
2016-07-31 |
| NCT02935036 |
Efficacy Study in Patients With Acne Vulgaris. |
https://ClinicalTrials.gov/show/NCT02935036 |
Completed |
Taro Pharmaceuticals USA |
2017-01-24 |
| NCT02932306 |
Efficacy and Safety of IDP-121 and IDP-121 Vehicle Lotion in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02932306 |
Completed |
Bausch Health Americas, Inc. |
2017-02-22 |
| NCT02932267 |
Subject Reported Outcomes With Use of Adapalene 0.3% - Benzoyl Peroxide (BPO) 2.5% in Dark Skin Acne |
https://ClinicalTrials.gov/show/NCT02932267 |
Completed |
Galderma |
2018-01-10 |
| NCT02929719 |
Study Comparing Test to Aczone 5% and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02929719 |
Completed |
Taro Pharmaceuticals USA |
2016-06-30 |
| NCT02913001 |
The Effect of a Low Glycemic Load Diet on Hormonal Markers Associated With Acne |
https://ClinicalTrials.gov/show/NCT02913001 |
Completed |
New York University |
2015-11-30 |
| NCT02905851 |
Teledermatology and Modulation of Antibiotic Dose in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02905851 |
Completed |
University of California, Davis |
2018-05-31 |
| NCT02899000 |
A Treatment for Severe Inflammatory Acne Subjects |
https://ClinicalTrials.gov/show/NCT02899000 |
Completed |
Galderma Laboratories, L.P. |
2017-03-28 |
| NCT02886715 |
A Study Comparing Tazarotene Cream 0.1% to TAZORAC® (Tazarotene) Cream 0.1% and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02886715 |
Completed |
Fougera Pharmaceuticals Inc. |
2017-05-31 |
| NCT02865005 |
Trial of Dapsone 5.0% Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02865005 |
Completed |
Seegpharm S.A. |
2016-11-30 |
| NCT02849860 |
Absorption and Systematic Pharmacokinetics of IDP-121 Lotion in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02849860 |
Completed |
Bausch Health Americas, Inc. |
2016-09-30 |
| NCT02832063 |
Clinical Trial in Subjects With Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02832063 |
Completed |
AOBiome LLC |
2017-07-19 |
| NCT02815332 |
BPX-01 Minocycline Topical Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02815332 |
Completed |
BioPharmX, Inc. |
2017-03-24 |
| NCT02815280 |
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne |
https://ClinicalTrials.gov/show/NCT02815280 |
Completed |
Foamix Ltd. |
2017-10-13 |
| NCT02815267 |
A Study to Compare the Efficacy and Safety of Topical Administration of FMX-101 for Treatment of Moderate-to-Severe Acne |
https://ClinicalTrials.gov/show/NCT02815267 |
Completed |
Foamix Ltd. |
2017-10-13 |
| NCT02801903 |
Pharmacokinetics of Topical SB204 in Adolescents With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02801903 |
Completed |
Novan, Inc. |
2016-08-31 |
| NCT02798120 |
P3 Long Term Safety Study of Once Daily SB204 in Acne |
https://ClinicalTrials.gov/show/NCT02798120 |
Completed |
Novan, Inc. |
2017-04-30 |
| NCT02774590 |
Timolol for the Treatment of Acne and Rosacea |
https://ClinicalTrials.gov/show/NCT02774590 |
Recruiting |
Johns Hopkins University |
2025-03-31 |
| NCT02758041 |
A Study to Evaluate Sebacia Microparticles in Patients With Inflammatory Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02758041 |
Completed |
Sebacia, Inc. |
2017-01-31 |
| NCT02755545 |
A Clinical Trial to Evaluate the Efficacy of Two Acne Treatments |
https://ClinicalTrials.gov/show/NCT02755545 |
Completed |
Galderma Laboratories, L.P. |
2017-04-04 |
| NCT02735421 |
Adapalene 0.3% - Benzoyl Peroxide 2.5% Gel and Risk of Formation of Atrophic Acne Scars |
https://ClinicalTrials.gov/show/NCT02735421 |
Completed |
Galderma |
2017-06-05 |
| NCT02731105 |
Pilot Study of Tolerability and Effectivity of Two Combination Topical Acne Products |
https://ClinicalTrials.gov/show/NCT02731105 |
Completed |
GWT-TUD GmbH |
2017-02-21 |
| NCT02721173 |
Tazarotene Plus Clindamycin vs. Adapalene Plus Clindamycin in the Treatment of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02721173 |
Completed |
All India Institute of Medical Sciences, Bhubaneswar |
2016-12-31 |
| NCT02720627 |
An Evaluation of the Adrenal Suppression Potential and PK of CB-03-01 Cream in Pediatric Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02720627 |
Completed |
Cassiopea SpA |
2018-03-21 |
| NCT02713607 |
Lipidome and Microbiome Profile of Acne |
https://ClinicalTrials.gov/show/NCT02713607 |
Active, not recruiting |
University of California, Davis |
2027-01-31 |
| NCT02709902 |
Study Comparing Adapalene/BP Gel to EPIDUO® FORTE and Both to a Placebo Control in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02709902 |
Completed |
Taro Pharmaceuticals USA |
2016-02-29 |
| NCT02709096 |
BPX-01 Minocycline 1% Topical Gel for Reduction of Propionibacterium Acnes |
https://ClinicalTrials.gov/show/NCT02709096 |
Completed |
BioPharmX, Inc. |
2016-06-30 |
| NCT02698436 |
A Study to Evaluate the Effectiveness and Tolerance of Two Acne Treatments on Subjects With Mild to Moderate Acne. |
https://ClinicalTrials.gov/show/NCT02698436 |
Completed |
Johnson & Johnson Consumer and Personal Products Worldwide |
2016-08-31 |
| NCT02682264 |
An Open-Label, Long-Term Extension Study to Evaluate the Safety of CB-03-01 Cream, 1% in Participants With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02682264 |
Completed |
Cassiopea SpA |
2018-08-31 |
| NCT02672332 |
P3 Study in Acne Comparing Once Daily SB204 and Vehicle |
https://ClinicalTrials.gov/show/NCT02672332 |
Completed |
Novan, Inc. |
2016-12-31 |
| NCT02667444 |
P3 Study Comparing Once Daily SB204 and Vehicle Gel in Acne |
https://ClinicalTrials.gov/show/NCT02667444 |
Completed |
Novan, Inc. |
2016-12-31 |
| NCT02661958 |
Efficacy, Safety, and Tolerability of S6G5T-1 and S6G5T-3 for the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02661958 |
Completed |
Sol-Gel Technologies, Ltd. |
2017-10-31 |
| NCT02656485 |
A Double Blind, Placebo-Controlled, Randomized Study in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02656485 |
Completed |
AOBiome LLC |
2016-03-01 |
| NCT02656043 |
A Safety, Tolerability, Efficacy and Exposure Study of XEN801 Topical Gel |
https://ClinicalTrials.gov/show/NCT02656043 |
Completed |
Xenon Pharmaceuticals Inc. |
2017-02-16 |
| NCT02646917 |
SkinPen Efficacy on Acne Scars on the Face and/or Back |
https://ClinicalTrials.gov/show/NCT02646917 |
Completed |
Bellus Medical, LLC |
2016-12-31 |
| NCT02643628 |
A Pilot Study to Evaluate the Safety and Effectiveness of Microneedling and Bellafill to Treat Facial Acne Scars |
https://ClinicalTrials.gov/show/NCT02643628 |
Completed |
Suneva Medical, Inc. |
2017-06-05 |
| NCT02620813 |
De Novo Lipogenesis of Sebaceous Glands in Acne |
https://ClinicalTrials.gov/show/NCT02620813 |
Completed |
University of California, Davis |
2017-10-12 |
| NCT02616614 |
Double-blind Placebo-controlled Trial of Generic Clindamycin/Benzoyl Peroxide Gel Versus Onexton Gel in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02616614 |
Completed |
Actavis Inc. |
2015-10-31 |
| NCT02608476 |
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (26) |
https://ClinicalTrials.gov/show/NCT02608476 |
Completed |
Cassiopea SpA |
2018-02-21 |
| NCT02608450 |
A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25) |
https://ClinicalTrials.gov/show/NCT02608450 |
Completed |
Cassiopea SpA |
2018-04-11 |
| NCT02604680 |
A Safety and Efficacy Evaluation of Topical Treatments for Moderate-Severe Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02604680 |
Completed |
Braintree Laboratories |
2016-06-30 |
| NCT02595034 |
A Study CLBG and Benzoyl Peroxide Gel 1%/5% to BenzaClin® Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02595034 |
Completed |
Taro Pharmaceuticals USA |
2015-10-31 |
| NCT02593383 |
Compound Adapalene and Clindamycin Hydrochloride Gel in Treatment of Patients With Acne |
https://ClinicalTrials.gov/show/NCT02593383 |
Completed |
Lee’s Pharmaceutical Limited |
2017-07-31 |
| NCT02589405 |
Benzac 5% Gel in Combination With Cosmetic Products in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02589405 |
Completed |
Galderma |
2016-01-31 |
| NCT02578043 |
A Study Comparing Clindamycin and Benzoyl Peroxide Gel 1.2%/3.75% to Onextonâ„¢ Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02578043 |
Completed |
Taro Pharmaceuticals USA |
2015-08-31 |
| NCT02575950 |
Explorative Trial Evaluating the Efficacy and Tolerability of LEO43204 in Moderate to Severe Acne |
https://ClinicalTrials.gov/show/NCT02575950 |
Completed |
LEO Pharma |
2017-04-30 |
| NCT02571998 |
A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02571998 |
Completed |
Maruho Co., Ltd. |
2016-08-31 |
| NCT03402893 |
The Use of Onexton in Moderate Acne Vulgaris for Patients With Skin of Color |
https://ClinicalTrials.gov/show/NCT03402893 |
Completed |
Derm Research, PLLC |
2017-11-15 |
| NCT02566369 |
Efficacy and Safety of CD5789 (Trifarotene) 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02566369 |
Completed |
Galderma R&D |
2017-11-14 |
| NCT02557399 |
DUAC® Early Onset Efficacy Study in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT02557399 |
Completed |
GlaxoSmithKline |
2015-12-17 |
| NCT00835198 |
Dapsone Gel 5% and Tretinoin Gel 0.025% Versus Tretinoin Gel 0.025% Monotherapy for Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00835198 |
Completed |
Allergan |
2009-08-31 |
| NCT02524665 |
8 Week Study to Evaluate and Compare the Efficacy and Tolerability of MAXCLARITY II and MURAD To Treat Acne |
https://ClinicalTrials.gov/show/NCT02524665 |
Completed |
GlaxoSmithKline |
2009-12-31 |
| NCT02502669 |
Finasteride Treatment of Severe Nodulocystic Acne |
https://ClinicalTrials.gov/show/NCT02502669 |
Completed |
Elorac, Inc. |
2017-06-06 |
| NCT02498288 |
A Study to Determine Bioequivalence of Isotretinoin in Healthy Male Subjects Under Fed Condition |
https://ClinicalTrials.gov/show/NCT02498288 |
Completed |
GlaxoSmithKline |
2013-07-15 |
| NCT02465632 |
To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. |
https://ClinicalTrials.gov/show/NCT02465632 |
Completed |
Glenmark Pharmaceuticals Ltd. India |
2015-11-30 |
| NCT02457520 |
ABSORICA in Patients With Severe Recalcitrant Nodular Acne |
https://ClinicalTrials.gov/show/NCT02457520 |
Completed |
Sun Pharmaceutical Industries Limited |
2018-04-30 |
| NCT02431052 |
A Dose-ranging Study of DRM01 in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02431052 |
Completed |
Dermira, Inc. |
2016-04-30 |
| NCT02411955 |
A Study Comparing Tazarotene Cream 0.1% to Tazorac® and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02411955 |
Completed |
Taro Pharmaceuticals USA |
2015-01-31 |
| NCT02411942 |
Study Comparing Adapalene Gel 0.3% to Differin® and Both to a Placebo Control in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02411942 |
Completed |
Taro Pharmaceuticals USA |
2015-02-28 |
| NCT02404285 |
A Study to Evaluate the Clinical Effect of Daily Next Scienceâ„¢ Acne Gel (NAG) on Mild to Moderate Facial Acne |
https://ClinicalTrials.gov/show/NCT02404285 |
Completed |
Next Science TM |
2015-09-30 |
| NCT02385760 |
CTX-4430 for the Treatment of Moderate to Severe Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02385760 |
Completed |
Celtaxsys, Inc. |
2016-05-31 |
| NCT02322866 |
Randomized, Double-blind, Placebo-controlled Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne |
https://ClinicalTrials.gov/show/NCT02322866 |
Completed |
Almirall, S.A. |
2017-01-12 |
| NCT02320149 |
Study to Evaluate Safety & Efficacy of Sarecycline in Treatment of Acne |
https://ClinicalTrials.gov/show/NCT02320149 |
Completed |
Almirall, S.A. |
2017-02-01 |
| NCT02313467 |
Topical PDT Cream Without Irradiation Source in the Acne Treatment |
https://ClinicalTrials.gov/show/NCT02313467 |
Completed |
Seoul National University Hospital |
2015-02-28 |
| NCT02307266 |
Patient Education in Adherence on Acne (PEAce) |
https://ClinicalTrials.gov/show/NCT02307266 |
Completed |
Galderma |
2015-06-30 |
| NCT02293018 |
Pharmacokinetic Study of MTC896 Gel in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT02293018 |
Completed |
Mimetica Pty Limited |
2015-01-31 |
| NCT02267746 |
A Study To Evaluate The Safety And Therapeutic Equivalence of Tazarotene Foam 0.1% in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02267746 |
Completed |
Actavis Inc. |
2014-09-30 |
| NCT02250430 |
A Phase 1 Study Assessing Local Cutaneous Effects of SB204 |
https://ClinicalTrials.gov/show/NCT02250430 |
Completed |
Novan, Inc. |
2014-09-30 |
| NCT02249104 |
A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02249104 |
Completed |
Galderma Laboratories, L.P. |
2015-02-28 |
| NCT02242760 |
P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02242760 |
Completed |
Novan, Inc. |
2015-06-30 |
| NCT02219074 |
Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02219074 |
Completed |
Sebacia, Inc. |
2016-10-31 |
| NCT02218034 |
Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02218034 |
Completed |
Allergan |
2015-03-31 |
| NCT02217228 |
Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02217228 |
Completed |
Sebacia, Inc. |
2015-12-31 |
| NCT02207738 |
Comparison of Efficacy Between Fractional Microneedling Radiofrequency and Bipolar Radiofrequency for Acne Scar |
https://ClinicalTrials.gov/show/NCT02207738 |
Completed |
Seoul National University Hospital |
2013-05-31 |
| NCT02205892 |
Clinical Study for Topical Lupeol in Acne |
https://ClinicalTrials.gov/show/NCT02205892 |
Completed |
Seoul National University Hospital |
2014-09-30 |
| NCT02189629 |
CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02189629 |
Completed |
Galderma R&D |
2017-02-23 |
| NCT02173054 |
An Efficiency of a Moisturizer Containing Licochalcone A, L-carnitine and 1,2-decanediol With Adapalene Gel in Acne |
https://ClinicalTrials.gov/show/NCT02173054 |
Completed |
Mahidol University |
2015-02-28 |
| NCT02164084 |
A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02164084 |
Completed |
Novan, Inc. |
2014-06-30 |
| NCT02160678 |
Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02160678 |
Completed |
G & W Laboratories Inc. |
2015-07-31 |
| NCT02145364 |
Ultherapy® for the Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT02145364 |
Completed |
Merz North America, Inc. |
2015-07-31 |
| NCT02103127 |
Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT02103127 |
Completed |
Cynosure, Inc. |
2015-05-31 |
| NCT02103816 |
The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars |
https://ClinicalTrials.gov/show/NCT02103816 |
Completed |
Cynosure, Inc. |
2015-02-28 |
| NCT02073461 |
Efficacy and Safety Study of 2 Different Concentrations of CD1579 Gels Versus Vehicle in the Treatment of Acne Vulgaris. |
https://ClinicalTrials.gov/show/NCT02073461 |
Completed |
Galderma R&D |
2014-10-31 |
| NCT02073448 |
Efficacy and Safety Study of GK530G Versus CD0271 0.1% Gel and CD1579 2.5% Gel in the Treatment of Acne Vulgaris. |
https://ClinicalTrials.gov/show/NCT02073448 |
Completed |
Galderma R&D |
2014-10-31 |
| NCT02066545 |
Safety and Efficacy Study of CLS001Topical Gel Compared to Vehicle in Subjects With Inflammatory Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02066545 |
Completed |
Maruho Co., Ltd. |
2014-11-30 |
| NCT01313728 |
A Study That Evaluates the Decrease in Irritation When Using Additional Acne Treatment Products |
https://ClinicalTrials.gov/show/NCT01313728 |
Completed |
Bausch Health Americas, Inc. |
2010-12-31 |
| NCT01293552 |
Clinical Trial To Evaluate ANT-1207 In Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01293552 |
Completed |
Anterios Inc. |
2012-04-30 |
| NCT01289574 |
Topical ASC-J9 Cream for Acne |
https://ClinicalTrials.gov/show/NCT01289574 |
Completed |
AndroScience Corp |
2012-07-31 |
| NCT02032407 |
A Study of Dapsone Gel in Females With Skin of Color and Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02032407 |
Completed |
Allergan |
2014-06-30 |
| NCT02031718 |
Comparison Between Interactive Internet-based Education and Counseling for the Management of Acne With That of Internet-based Education Alone |
https://ClinicalTrials.gov/show/NCT02031718 |
Completed |
University of California, Davis |
2014-07-31 |
| NCT02005666 |
To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel |
https://ClinicalTrials.gov/show/NCT02005666 |
Completed |
Cadila Healthcare Limited |
2016-09-28 |
| NCT01984801 |
Study to Investigate the Irritation Potential of GSK1940029 Gel |
https://ClinicalTrials.gov/show/NCT01984801 |
Completed |
GlaxoSmithKline |
2015-04-10 |
| NCT01974141 |
A Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01974141 |
Completed |
Almirall, S.A. |
2014-10-31 |
| NCT01951417 |
Adapalene BPO Gel Pump, Moisturizer SPF 30 and Foam Wash in Patients With Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01951417 |
Completed |
Galderma Laboratories, L.P. |
2014-03-31 |
| NCT01938482 |
Study to Evaluate the Safety, Tolerability and Pharmacokinetic of Single and 14 Day Repeat Topical Application of GSK1940029 |
https://ClinicalTrials.gov/show/NCT01938482 |
Completed |
GlaxoSmithKline |
2015-02-17 |
| NCT01936324 |
A Safety, Tolerability and Preliminary Efficacy Study of DRM01B Topical Gel |
https://ClinicalTrials.gov/show/NCT01936324 |
Completed |
Dermira, Inc. |
2014-06-30 |
| NCT01930565 |
Effectiveness and Safety of New Botanical Component-LFCO- Compared With Existing TTO in Clinical Study |
https://ClinicalTrials.gov/show/NCT01930565 |
Completed |
Seoul National University Hospital |
2013-07-31 |
| NCT01929278 |
W0265-103: A Single-Center, Evaluator-Blinded, Randomized, Placebo Controlled, Phase 1 Clinical Trial Evaluating The Phototoxic Potential Of Topically Applied Clindamycin 1.0% - Tretinoin 0.025% Gel (Ct Gel) In Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01929278 |
Completed |
GlaxoSmithKline |
2008-12-19 |
| NCT01915758 |
W0265-104: A Single-Center, Evaluator-Blinded, Randomized, Placebo-Controlled, Phase 1 Clinical Trial Evaluating the Photoallergic Potential of Topically Applied Clindamycin Phosphate 1.0% and Tretinoin 0.025% (CT Gel) in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01915758 |
Completed |
GlaxoSmithKline |
2009-02-20 |
| NCT01915732 |
A Efficacy and Safety of Duacâ„¢Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01915732 |
Completed |
GlaxoSmithKline |
2014-04-30 |
| NCT01909713 |
Tolerability of a Foaming Facial Cleanser and Moisturizer SPF 30 in a Pediatric Population (7-11) With Acne Prone Skin. |
https://ClinicalTrials.gov/show/NCT01909713 |
Completed |
Galderma Laboratories, L.P. |
2013-06-30 |
| NCT01885910 |
Aczone 5% Gel as Maintenance Treatment of Acne Vulgaris Following Completion of Oral Doxycycline and Aczone 5% Gel |
https://ClinicalTrials.gov/show/NCT01885910 |
Completed |
Derm Research, PLLC |
2014-07-31 |
| NCT01880320 |
Multi-center, Randomized, Double-blind Efficacy and Safety of CD0271 0.3%/CD1579 2.5 % Topical Gel in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01880320 |
Completed |
Galderma R&D |
2014-03-31 |
| NCT01844752 |
A Phase 2, 3 Arm Study of NVN1000 Gel and Vehicle Gel in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01844752 |
Completed |
Novan, Inc. |
2013-11-30 |
| NCT01844739 |
A Phase 1 Study Evaluating Safety and Tolerability of NVN1000 Gel |
https://ClinicalTrials.gov/show/NCT01844739 |
Completed |
Novan, Inc. |
2013-06-30 |
| NCT01831960 |
An Evaluation of the Adrenal Suppression Potential and Pharmacokinetic Properties of CB-03-01 Cream in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01831960 |
Completed |
Intrepid Therapeutics, Inc. |
2013-11-30 |
| NCT01830764 |
Open-label Safety and Tolerability Study of LTS-PDT in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01830764 |
Completed |
Dermira, Inc. |
2013-06-30 |
| NCT01815450 |
BLI1100-202: BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01815450 |
Completed |
Braintree Laboratories |
2013-11-30 |
| NCT01807455 |
An Open, Non-comparative Study of the Efficacy and Safety of Treatment of Acne Scars With Restylane Vital Lidocaine |
https://ClinicalTrials.gov/show/NCT01807455 |
Completed |
Q-Med AB |
2014-12-31 |
| NCT01796665 |
A Study to Compare Clindamycin Phosphate and Benzoyl Peroxide Topical Gel 1.2%/2.5% to Acanya® Topical Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01796665 |
Completed |
Perrigo Company |
2013-02-28 |
| NCT01788384 |
Evaluate Therapeutic Equivalence and Safety of Two Clindamycin Phosphate and Benzoyl Peroxide Gels in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01788384 |
Completed |
Watson Laboratories, Inc. |
2012-12-31 |
| NCT01773122 |
Safety, Tolerability, and Pharmacokinetics of Dapsone in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01773122 |
Completed |
Allergan |
2013-05-05 |
| NCT01769235 |
Study Comparing Clindamycin Phosphate and Benzoyl Peroxide Gel to Acanya® Gel and Both to a Vehicle Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01769235 |
Completed |
Taro Pharmaceuticals USA |
2013-09-30 |
| NCT01755247 |
A Phase 1, 3 Day Study of Safety and Tolerability of NVN1000 Topical Gel in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01755247 |
Completed |
Novan, Inc. |
2012-11-30 |
| NCT01742637 |
Study Comparing Adapalene and Benzoyl Peroxide Gel 0.1%/2.5% to Epiduo® and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01742637 |
Completed |
Taro Pharmaceuticals USA |
2014-02-28 |
| NCT01706263 |
U0289-402: An Open Label, 8 Week Study to Evaluate the Efficacy and Tolerability of MAXCLARITY II in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01706263 |
Completed |
GlaxoSmithKline |
2009-11-20 |
| NCT01706250 |
U0289-401: Eight Week, Split-face, Study to Determine and Compare the Efficacy and Tolerability of MAXCLARITYâ„¢ II to PROACTIVâ„¢ |
https://ClinicalTrials.gov/show/NCT01706250 |
Completed |
GlaxoSmithKline |
2010-01-01 |
| NCT01701024 |
Clinical Study to Test the Efficacy and Safety of ACYC to Treat Moderate to Severe Acne |
https://ClinicalTrials.gov/show/NCT01701024 |
Completed |
Bausch Health Americas, Inc. |
2013-05-31 |
| NCT01696513 |
Effect of Subcision and Suction on Acne Scars |
https://ClinicalTrials.gov/show/NCT01696513 |
Active, not recruiting |
Northwestern University |
2020-12-31 |
| NCT01694810 |
Cutaneous Tolerability and Safety of NVN1000 Topical Gel in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01694810 |
Completed |
Novan, Inc. |
2012-11-30 |
| NCT01694433 |
“Clinical Trial to Determine the Efficacy of Vitamin D for Acne Therapy” |
https://ClinicalTrials.gov/show/NCT01694433 |
Completed |
University of California, Los Angeles |
2014-01-09 |
| NCT01689935 |
Reduced Side-Effects Of Photodynamic Therapy For The Treatment Of Moderate To Severe Acne (i-PDT) |
https://ClinicalTrials.gov/show/NCT01689935 |
Completed |
Massachusetts General Hospital |
2013-09-30 |
| NCT01688531 |
A Pilot Study to Investigate Filiation Between Primary and Secondary Lesions in Acne Patients |
https://ClinicalTrials.gov/show/NCT01688531 |
Completed |
Galderma R&D |
2013-09-30 |
| NCT01687556 |
EGCG Improves Acne by Modulating Molecular Targets |
https://ClinicalTrials.gov/show/NCT01687556 |
Completed |
Seoul National University Hospital |
2006-06-30 |
| NCT01682200 |
Clinical Trial on the Effects and Side Effects of ProOxy in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT01682200 |
Completed |
Medivet Pty Ltd |
2010-03-31 |
| NCT01678482 |
Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne Treatment |
https://ClinicalTrials.gov/show/NCT01678482 |
Completed |
Home Skinovations Ltd. |
2012-04-30 |
| NCT01677221 |
Effects of Acleara Needle Insert on Acne |
https://ClinicalTrials.gov/show/NCT01677221 |
Completed |
Theravant Corporation |
2013-01-31 |
| NCT01631474 |
A Phase 2 Dose Escalating Study to Evaluate the Safety and Efficacy of CB-03-01 Cream in Subjects With Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01631474 |
Completed |
Intrepid Therapeutics, Inc. |
2014-02-28 |
| NCT01629797 |
Knowledge Evaluation and Assessment of the Effectiveness of an Education Intervention on Acne |
https://ClinicalTrials.gov/show/NCT01629797 |
Completed |
Northwestern University |
2012-11-30 |
| NCT01628549 |
Double-Blind, Placebo-Controlled Study to Evaluate 3 Doses of a Novel Tetracycline in the Treatment of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01628549 |
Completed |
Almirall, S.A. |
2012-11-16 |
| NCT01616654 |
Dose Range Study of CD5789 in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01616654 |
Completed |
Galderma |
2013-07-31 |
| NCT01584674 |
A Clinical Trial Evaluating the Safety and Efficacy of the KLOX Biophotonic System in Moderate to Severe Acne |
https://ClinicalTrials.gov/show/NCT01584674 |
Completed |
KLOX Technologies Inc. |
2013-04-30 |
| NCT01556698 |
Study of NVN1000 Topical Gel and Topical Gel Vehicle in the Treatment of Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01556698 |
Completed |
Novan, Inc. |
2011-12-31 |
| NCT01527123 |
A Study to Evaluate the Pharmacokinetics of Benzoic Acid and Hippuric Acid After Topical Administration of GSK2585823 in Japanese Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01527123 |
Completed |
GlaxoSmithKline |
2012-06-01 |
| NCT01522456 |
Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel |
https://ClinicalTrials.gov/show/NCT01522456 |
Completed |
Galderma Laboratories, L.P. |
2012-05-31 |
| NCT01504204 |
Effect of Samples on Acne Treatment With Epiduo® Gel |
https://ClinicalTrials.gov/show/NCT01504204 |
Completed |
Wake Forest University Health Sciences |
2012-11-30 |
| NCT01501799 |
A Bioequivalence Study With Clinical Endpoints Comparing Adapalene and Benzoyl Peroxide Topical Gel 0.1%/2.5% (Actavis Mid-Atlantic LLC) To Epiduoâ„¢ (Adapalene and Benzoyl Peroxide) Gel 0.1%/2.5% (Galderma Laboratories, L.P.) in the Treatment of Mild to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01501799 |
Completed |
Actavis Mid-Atlantic LLC |
2011-12-31 |
| NCT01498874 |
Efficacy and Safety Study of Gevokizumab to Treat Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01498874 |
Completed |
XOMA (US) LLC |
2013-04-30 |
| NCT01494285 |
Clinical Study to Evaluate Tolerability and Safety of ARK-E021 Foam and to Monitor Clinical Effect in Acne Vulgaris Patients |
https://ClinicalTrials.gov/show/NCT01494285 |
Completed |
M. Arkin 1999 Ltd. |
2013-10-31 |
| NCT01492647 |
A Study of JNJ 10229570-AAA to Evaluate Safety and Tolerability in Japanese Participants With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01492647 |
Completed |
Janssen Pharmaceutical K.K. |
2011-10-31 |
| NCT01490736 |
Phase 1/2 Sequentially Staged Safety Study in Healthy Subjects and Subjects With Mild Acne |
https://ClinicalTrials.gov/show/NCT01490736 |
Completed |
Dermira, Inc. |
2013-03-31 |
| NCT01474798 |
Phase II Trial of RA-18C3 in Subjects With Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01474798 |
Completed |
XBiotech, Inc. |
2012-10-31 |
| NCT01474590 |
Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne |
https://ClinicalTrials.gov/show/NCT01474590 |
Completed |
Galderma |
2013-07-31 |
| NCT01472900 |
2940nm Er:YAG Laser Versus Benzoyl Peroxide Gel for the Treatment of Inflammatory Acne |
https://ClinicalTrials.gov/show/NCT01472900 |
Completed |
Chulalongkorn University |
2012-04-30 |
| NCT01466673 |
An Efficacy and Safety Study Comparing Oral Contraceptive Containing Norgestimate or Desogestrel for Acne Treatment |
https://ClinicalTrials.gov/show/NCT01466673 |
Completed |
Janssen-Cilag Ltd.,Thailand |
2010-03-31 |
| NCT01461655 |
Efficacy and the Tolerability of the Sequential Application of Two Marketed Products in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01461655 |
Completed |
LEO Pharma |
2012-04-30 |
| NCT01446237 |
U0289-405: An Open-Label, 12-Week Study to Evaluate the Efficacy and Safety of the Acne System (Benzoyl Peroxide 2.5%, Salicylic Acid 0.5%) in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01446237 |
Completed |
GlaxoSmithKline |
2011-12-01 |
| NCT01445301 |
Study STF115287, a Clinical Confirmation Study of GSK2585823 in the Treatment of Acne Vulgaris in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01445301 |
Completed |
GlaxoSmithKline |
2012-08-02 |
| NCT01428466 |
Japanese Phase 1 Study of GSK2585823 |
https://ClinicalTrials.gov/show/NCT01428466 |
Completed |
GlaxoSmithKline |
2011-02-15 |
| NCT01404130 |
A Pilot Study of the Effects of Isotretinoin on Cognition, Learning and Memory |
https://ClinicalTrials.gov/show/NCT01404130 |
Completed |
University of Aberdeen |
2010-11-30 |
| NCT01400932 |
Study STF115288, a Clinical Confirmation Study of GI148512 in the Treatment of Acne Vulgaris in Japanese Subjects |
https://ClinicalTrials.gov/show/NCT01400932 |
Completed |
GlaxoSmithKline |
2012-04-30 |
| NCT01399970 |
Use of Mobile Teledermatology in the Care of Acne Patients |
https://ClinicalTrials.gov/show/NCT01399970 |
Completed |
Medical University of Graz |
2012-12-31 |
| NCT01387048 |
Study for Long-term Treatment of Acne Vulgaris With Skinoren Versus Differin |
https://ClinicalTrials.gov/show/NCT01387048 |
Completed |
University of Magdeburg |
2012-08-31 |
| NCT01362010 |
Clinical Study to Evaluate Tolerability and Safety of FXFM244 and to Monitor Clinical Effect in Acne Vulgaris Patients |
https://ClinicalTrials.gov/show/NCT01362010 |
Completed |
Foamix Ltd. |
2013-06-30 |
| NCT01348321 |
Comparison of Efficacy of Azithromycin and Levamisole Versus of Azithromycin in in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT01348321 |
Completed |
Ahvaz Jundishapur University of Medical Sciences |
2009-10-31 |
| NCT01347879 |
A Double Blinded, Prospective, Randomized, Vehicle Controlled Multi-center Study of Photodynamic Therapy With Visonac® Cream in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01347879 |
Completed |
Photocure |
2012-04-30 |
| NCT01326780 |
A Study of a New Drug Treatment for Acne |
https://ClinicalTrials.gov/show/NCT01326780 |
Completed |
Bausch Health Americas, Inc. |
2012-03-31 |
| NCT01321645 |
Efficacy of Azadirachta Indica (Homoeopathic Medicine) in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01321645 |
Completed |
Miglani, Anjali |
2012-05-31 |
| NCT01321632 |
Efficacy of Zingiber Officinalis (Homoeopathic Medicine) in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01321632 |
Completed |
Miglani, Anjali |
2012-06-30 |
| NCT01320033 |
Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01320033 |
Completed |
Galderma |
2012-01-03 |
| NCT04433143 |
Evaluate the Efficacy and Safety of Intense Pulsed Light Filters Combined With Oral Medication in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT04433143 |
Enrolling by invitation |
Xijing Hospital |
2021-05-06 |
| NCT04321070 |
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04321070 |
Completed |
Taro Pharmaceuticals USA |
2019-12-14 |
| NCT04300010 |
Blue Light Therapy of C. Acnes |
https://ClinicalTrials.gov/show/NCT04300010 |
Recruiting |
University of Wisconsin, Madison |
2022-03-31 |
| NCT04254601 |
Laser Therapy Versus Narrow Band Ultraviolet B for the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04254601 |
Completed |
Cairo University |
2019-06-30 |
| NCT04216160 |
Skin Acceptance and Efficacy Assessment of a Topical Product in Acne Treatment When Compared to a Placebo. |
https://ClinicalTrials.gov/show/NCT04216160 |
Active, not recruiting |
YUN NV |
2019-11-28 |
| NCT04214639 |
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04214639 |
Recruiting |
Bausch Health Americas, Inc. |
2020-07-31 |
| NCT04213638 |
Trial of Single Microneedle Radiofrequency for Moderateâ€toâ€Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04213638 |
Recruiting |
Xiangya Hospital of Central South University |
2020-11-30 |
| NCT04206631 |
Comedone Extraction and Oral Doxycycline In The First Line Treatment of Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04206631 |
Completed |
Indonesia University |
2015-09-30 |
| NCT04167982 |
Efficacy and Safety of Painless 5-aminolevulinic Acid Photodynamic Therapy for Moderate and Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04167982 |
Recruiting |
Shanghai Dermatology Hospital |
2022-11-30 |
| NCT04163263 |
Study to Evaluate the Safety, Tolerability, Pharmacokinetic, and Pharmacodynamic Effects of Repeat Topical Application of BOS-356 in Subjects With Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04163263 |
Recruiting |
Boston Pharmaceuticals |
2020-07-31 |
| NCT04156815 |
Treatment of Acne Vulgaris Using NAFL in Combination With Isotretinoin and Pricking Blood Therapy |
https://ClinicalTrials.gov/show/NCT04156815 |
Completed |
Xijing Hospital |
2018-10-05 |
| NCT04106778 |
DMT310-003 Topical in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04106778 |
Recruiting |
Dermata Therapeutics |
2020-06-30 |
| NCT04134273 |
Bio-equivalence Study With Clinical Endpoints in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04134273 |
Completed |
Taro Pharmaceuticals USA |
2019-09-17 |
| NCT04118296 |
Decreasing Severity of Acne Vulgaris After the Use of a Combination of Anti-Acne Cream |
https://ClinicalTrials.gov/show/NCT04118296 |
Completed |
Sukma Skin Treatment |
2019-11-06 |
| NCT04104685 |
A Study to Compare FCD105 Foam to Minocycline 3% Foam, Adapalene 0.3% Foam and Vehicle Foam. |
https://ClinicalTrials.gov/show/NCT04104685 |
Active, not recruiting |
Foamix Ltd. |
2020-02-28 |
| NCT04059523 |
MUSE Study to Evaluate the Pharmacokinetics, Safety and Tolerability of S6G5T-3 |
https://ClinicalTrials.gov/show/NCT04059523 |
Completed |
Sol-Gel Technologies, Ltd. |
2020-02-06 |
| NCT04057768 |
Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles |
https://ClinicalTrials.gov/show/NCT04057768 |
Active, not recruiting |
Venus Concept |
2020-07-19 |
| NCT04045119 |
Effect of a Facial Cream Containing Cannabidiol and Hemp Oil on Skin Hydration and Acne-prone Skin |
https://ClinicalTrials.gov/show/NCT04045119 |
Completed |
Avicanna Inc |
2020-01-02 |
| NCT04018885 |
A Study on Safety and Preliminary Efficacy of ALA in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04018885 |
Completed |
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. |
2020-01-20 |
| NCT04015375 |
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04015375 |
Completed |
Torrent Pharmaceuticals Limited |
2020-02-03 |
| NCT04002024 |
Moisturizer Containing Licochalcone A, Decanediol, L-carnitine and Salicylic Acid in Reducing Relapsing of Acne |
https://ClinicalTrials.gov/show/NCT04002024 |
Recruiting |
Mahidol University |
2020-04-01 |
| NCT03961607 |
Conventional Photodynamic Therapy vs. Painless Photodynamic Therapy for Moderate or Severe Acne |
https://ClinicalTrials.gov/show/NCT03961607 |
Recruiting |
Shanghai Dermatology Hospital |
2019-12-30 |
| NCT03933033 |
Erbium-YAG Laser Versus Platelet Rich Plasma in the Treatment of Atrophic Acne Scars |
https://ClinicalTrials.gov/show/NCT03933033 |
Completed |
Aswan University Hospital |
2018-08-31 |
| NCT03915860 |
Subject Reported Outcomes With Use of Trifarotene 50 μg/g Cream in the Treatment of Moderate Facial and Truncal Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03915860 |
Completed |
Galderma R&D |
2019-12-23 |
| NCT03901417 |
Comparison of 1550nm Fractional Laser Alone Versus in Combination With Microneedling for the Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT03901417 |
Active, not recruiting |
Massachusetts General Hospital |
2020-06-30 |
| NCT03900676 |
Efficacy and Safety Study of VB-1953 Topical Gel for Inflammatory Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03900676 |
Active, not recruiting |
Vyome Therapeutics Inc. |
2019-11-30 |
| NCT03883269 |
Anti-inflammatory Effects of Topical Erythromycin and Clindamycin in Acne Patients |
https://ClinicalTrials.gov/show/NCT03883269 |
Recruiting |
Centre for Human Drug Research, Netherlands |
2019-06-30 |
| NCT03878238 |
A Pilot Study to Evaluate the Effect of a Probiotic Mixture in Acne |
https://ClinicalTrials.gov/show/NCT03878238 |
Completed |
Bionou Research, S.L. |
2019-04-15 |
| NCT03850925 |
Comparison of Picosecond Pulsed Nd:YAG Laser and Fractional Laser for the Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT03850925 |
Recruiting |
Dongtan Sacred Heart Hospital |
2020-04-30 |
| NCT03818555 |
Sebacia Postmarket Study of Real-World Use |
https://ClinicalTrials.gov/show/NCT03818555 |
Active, not recruiting |
Sebacia, Inc. |
2020-06-30 |
| NCT03761810 |
A Study of S6G5T 3 in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03761810 |
Completed |
Sol-Gel Technologies, Ltd. |
2019-12-11 |
| NCT03761784 |
A Study of S6G5T-3 in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03761784 |
Completed |
Sol-Gel Technologies, Ltd. |
2019-12-17 |
| NCT03743038 |
A Study Comparing Two Topicals in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03743038 |
Completed |
Foamix Ltd. |
2019-02-11 |
| NCT03717506 |
Bioequivalence Study of Clindamycin Phosphate Topical Lotion, 1% in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03717506 |
Active, not recruiting |
Gage Development Company, LLC |
2020-06-30 |
| NCT03709654 |
A Study of the Safety, Engraftment, and Action of Multi-Dosed NB01 in Adults With Moderate Acne |
https://ClinicalTrials.gov/show/NCT03709654 |
Active, not recruiting |
Naked Biome, Inc. |
2019-09-30 |
| NCT03653403 |
Open-Label, Randomized Study Evaluating the Absorption and Systemic Pharmacokinetics of Topically Applied IDP-126 Gel in Comparison With Control Gel |
https://ClinicalTrials.gov/show/NCT03653403 |
Completed |
Bausch Health Americas, Inc. |
2019-06-19 |
| NCT03650361 |
Bioequivalence Study of Adapalene Gel 0.3% in Subjects With Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03650361 |
Completed |
Aleor Dermaceuticals Limited |
2019-02-16 |
| NCT03626298 |
Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia |
https://ClinicalTrials.gov/show/NCT03626298 |
Completed |
Rumah Sakit Pusat Angkatan Darat Gatot Soebroto |
2016-12-31 |
| NCT03615768 |
A Study to Evaluate the Efficacy and Safety of Adapalene-Clindamycin Combination Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03615768 |
Completed |
Lee’s Pharmaceutical Limited |
2020-02-13 |
| NCT03599193 |
A Bioavailability Study of DFD-03 (Tazarotene, Lotion 0.1 % ) Compared to Tazorac® (Tazarotene), 0.1% in Patients With Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03599193 |
Completed |
Dr. Reddy’s Laboratories Limited |
2018-04-30 |
| NCT03585140 |
Low Glycemic Index and Load Diet for the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT03585140 |
Completed |
Centro Dermatológico Dr. Ladislao de la Pascua |
2016-05-01 |
| NCT03573518 |
Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03573518 |
Completed |
Botanix Pharmaceuticals |
2019-08-16 |
| NCT03573115 |
Multimodal Optical Imaging for Pretreatment Evaluation for Cutaneous Microparticle Delivery |
https://ClinicalTrials.gov/show/NCT03573115 |
Active, not recruiting |
Bispebjerg Hospital |
2018-07-18 |
| NCT03536637 |
DMT310-001 Topical in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03536637 |
Completed |
Dermata Therapeutics |
2018-12-30 |
| NCT03522922 |
Efficacy of Microneedling With Topical Vitamin C in Treatment of Acne Scarring |
https://ClinicalTrials.gov/show/NCT03522922 |
Completed |
Sohag University |
2018-02-01 |
| NCT03522441 |
Bioequivalence Study of Clindamycin Gel 1% in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03522441 |
Completed |
Akorn, Inc. |
2019-04-22 |
| NCT03497897 |
Study to Assess the Efficacy and Safety of LYS006 in Patients With Moderate to Severe Inflammatory Acne |
https://ClinicalTrials.gov/show/NCT03497897 |
Recruiting |
Novartis |
2020-11-16 |
| NCT03457636 |
The Use of Oracea and Epiduo Forte in Severe Acne Patients |
https://ClinicalTrials.gov/show/NCT03457636 |
Completed |
Derm Research, PLLC |
2018-11-01 |
| NCT03450369 |
A Study of the Safety, Engraftment, and Action of NB01 in Adults With Moderate Acne |
https://ClinicalTrials.gov/show/NCT03450369 |
Completed |
Naked Biome, Inc. |
2018-06-18 |
| NCT03433378 |
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.05% and RLD in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03433378 |
Completed |
Taro Pharmaceuticals USA |
2018-01-26 |
| NCT03427554 |
To Evaluate the Therapeutic Equivalence and Safety of TRETINOIN CREAM, 0.1% and RLD in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03427554 |
Completed |
Taro Pharmaceuticals USA |
2018-01-26 |
| NCT01257906 |
Bioequivalence Study Comparing Clindamycin Phosphate (1.2%) and Tretinoin (0.025%) Topical Gel to Ziana and Placebo |
https://ClinicalTrials.gov/show/NCT01257906 |
Completed |
Actavis Mid-Atlantic LLC |
2010-10-31 |
| NCT01245946 |
Photodynamic Therapy Compared to Adapalene 0.1% Gel Plus Doxycycline in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01245946 |
Completed |
Pontificia Universidad Catolica de Chile |
2011-05-31 |
| NCT01241331 |
BLI1100 for the Treatment of Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01241331 |
Completed |
Braintree Laboratories |
2011-04-30 |
| NCT01237821 |
Comparing OTC Acne Treatment to Prescription Regimen |
https://ClinicalTrials.gov/show/NCT01237821 |
Completed |
Milton S. Hershey Medical Center |
2011-08-31 |
| NCT01231334 |
A Study Comparing Aczone® Plus Differin® Versus Duac® Plus Differin® in Patients With Severe Facial Acne |
https://ClinicalTrials.gov/show/NCT01231334 |
Completed |
Allergan |
2011-06-30 |
| NCT01221922 |
Laser Treatment of Acne Scars in Fitzpatrick Skin Types III-VI |
https://ClinicalTrials.gov/show/NCT01221922 |
Completed |
Cynosure, Inc. |
2012-01-31 |
| NCT01213199 |
Adapalene Gel 0.3% in the Treatment of Atrophic Acne Scars |
https://ClinicalTrials.gov/show/NCT01213199 |
Completed |
Galderma |
2012-04-30 |
| NCT01209949 |
Assessment of Subjects’ Efficacy and Experiences Using Adapalene BPO Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01209949 |
Completed |
Galderma Laboratories, L.P. |
2011-01-31 |
| NCT01206348 |
Combination Treatment for Moderate to Severe Acne |
https://ClinicalTrials.gov/show/NCT01206348 |
Completed |
Medicis Global Service Corporation |
2011-07-31 |
| NCT01194375 |
A Dose-Ranging Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01194375 |
Completed |
Dow Pharmaceutical Sciences |
2011-12-31 |
| NCT01188538 |
Anti Propionibacterium(P.) Acnes Activity of Epiduo® Gel Compared to Benzoyl Peroxide (BPO) 2.5% Gel |
https://ClinicalTrials.gov/show/NCT01188538 |
Completed |
Galderma |
2010-08-31 |
| NCT01182636 |
Bioequivalence of Adapalene Topical Gel in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01182636 |
Completed |
Teva Pharmaceuticals USA |
2008-04-30 |
| NCT01180543 |
Acne Treatment With Active Oplon’s Patches |
https://ClinicalTrials.gov/show/NCT01180543 |
Completed |
Oplon-Pure Science Ltd. |
2010-10-31 |
| NCT01179633 |
Acne Treatment With Active Patches Which Contains Azelaic Acid, Citric Acid,Salicylic Acid and 2% Ascorbic Acid |
https://ClinicalTrials.gov/show/NCT01179633 |
Completed |
Oplon-Pure Science Ltd. |
2010-06-30 |
| NCT01176955 |
A Novel Method to Improve Acne Outcomes |
https://ClinicalTrials.gov/show/NCT01176955 |
Completed |
Wake Forest University Health Sciences |
2010-08-31 |
| NCT01162837 |
Safety & Effectiveness of the BEAM Device in Mild-to-moderate Acne |
https://ClinicalTrials.gov/show/NCT01162837 |
Completed |
Oregon Aesthetic Technologies |
2010-09-30 |
| NCT01160757 |
A Study to Determine the Safety and Efficacy of an Ultrasound Device in the Management of Acute Acne Lesions |
https://ClinicalTrials.gov/show/NCT01160757 |
Completed |
Arizona State University |
2009-07-31 |
| NCT01149330 |
Evaluation of Efficacy and Safety of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01149330 |
Completed |
Galderma Brasil Ltda. |
2011-03-31 |
| NCT01138735 |
Epiduo Pediatric Acne Study |
https://ClinicalTrials.gov/show/NCT01138735 |
Completed |
Galderma |
2011-08-31 |
| NCT01138514 |
Clinical Study Between Two Clindamycin 1%/Benzoyl Peroxide 5% Topical Gels |
https://ClinicalTrials.gov/show/NCT01138514 |
Completed |
Perrigo Company |
2010-10-31 |
| NCT01132443 |
W0261-101: A Phase 1, Single Center, Randomized, Open-Label Study to Evaluate the Bioavailability of Clindamycin From Clindamycin 1%-Benzoyl Peroxide 3% Gel, Topical Gel (Clindamycin 1%- Benzoyl Peroxide 5%), and Once Daily Gel (Clindamycin 1%-Benzoyl Peroxide 5%) in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01132443 |
Completed |
GlaxoSmithKline |
2010-06-12 |
| NCT01119651 |
A Study to Evaluate the Potential of Tazarotene Foam to Cause an Allergic Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers. |
https://ClinicalTrials.gov/show/NCT01119651 |
Completed |
GlaxoSmithKline |
2010-06-26 |
| NCT01115322 |
A Study to Evaluate the Potential of Tazarotene Foam to Cause a Reaction When Applied to the Skin and Exposed to Light on Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01115322 |
Completed |
GlaxoSmithKline |
2010-04-10 |
| NCT01114841 |
A Study To Evaluate The Contact Sensitization Potential Of Tazarotene Foam On Skin In Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01114841 |
Completed |
GlaxoSmithKline |
2010-06-26 |
| NCT01112787 |
A Study to Evaluate the Irritation Potential of Tazarotene Foam on Skin in Healthy Volunteers |
https://ClinicalTrials.gov/show/NCT01112787 |
Completed |
GlaxoSmithKline |
2010-04-26 |
| NCT01106807 |
Exploratory Study to Evaluate the Efficacy and Safety of CD07223 Gel in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT01106807 |
Completed |
Galderma |
2010-09-30 |
| NCT01095640 |
Study Comparing 0.3% Adapalene Topical Gel to Differin® 0.3% Adapalene Topical Gel |
https://ClinicalTrials.gov/show/NCT01095640 |
Completed |
Actavis Inc. |
2009-12-31 |
| NCT01052246 |
Pulsed Dye Laser Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01052246 |
Completed |
Laserklinik Karlsruhe |
2009-06-30 |
| NCT01050465 |
MedlinePlus Health Prescriptions: Developing a Pragmatic Approach for Clinic Use |
https://ClinicalTrials.gov/show/NCT01050465 |
Completed |
University of Missouri-Columbia |
2010-10-31 |
| NCT01047189 |
Adherence to Study Medication Compared to Generic Topical Clindamycin Plus Generic Topical Tretinoin in Subjects With Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01047189 |
Completed |
Wake Forest University Health Sciences |
2009-10-31 |
| NCT01044264 |
Clinical Study Between Two 1% Clindamycin/5% Benzoyl Peroxide Topical Gel Formulations |
https://ClinicalTrials.gov/show/NCT01044264 |
Completed |
Perrigo Company |
2008-09-30 |
| NCT01040390 |
Efficacy of Lappa Arctium (Homoeopathic Medicine) in Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01040390 |
Completed |
Miglani, Anjali |
2011-12-31 |
| NCT01038869 |
Efficacy and Safety Study of Finacea to Treat Acne Vulgaris and Post-Inflammatory Hyperpigmentation (PIH) |
https://ClinicalTrials.gov/show/NCT01038869 |
Completed |
Derm Research, PLLC |
2010-04-30 |
| NCT01019603 |
A Study to Evaluate the Bioavailability of Tazarotene Foam, 0.1%, and Tazorac Gel, 0.1%, in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01019603 |
Completed |
GlaxoSmithKline |
2009-12-20 |
| NCT01017146 |
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne - W0260-301 |
https://ClinicalTrials.gov/show/NCT01017146 |
Completed |
GlaxoSmithKline |
2010-11-30 |
| NCT01017120 |
A Study to Evaluate the Safety and Efficacy of Tazarotene Foam, 0.1%, in Subjects With Common Facial Acne |
https://ClinicalTrials.gov/show/NCT01017120 |
Completed |
GlaxoSmithKline |
2010-11-01 |
| NCT01016977 |
A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01016977 |
Completed |
GlaxoSmithKline |
2010-04-30 |
| NCT01015638 |
Compare the Tolerance of Clindamycin 1% /Benzoyl Peroxide (BPO) 5% Gel to Clindamycin 1.2%/ BPO 2.5% Topical Medications |
https://ClinicalTrials.gov/show/NCT01015638 |
Completed |
GlaxoSmithKline |
2009-09-30 |
| NCT01014689 |
Comparison of Epiduo Associated With Lymecycline Versus Epiduo Vehicle Associated With Lymecycline in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01014689 |
Completed |
Galderma |
2010-04-30 |
| NCT00991198 |
The Role of Topically Dissolved Oxygen (TDO) to Ameliorate Signs of Photodamage |
https://ClinicalTrials.gov/show/NCT00991198 |
Completed |
Aria Aesthetics Inc. |
2010-01-31 |
| NCT00975143 |
Efficacy and Safety of CIP-Isotretinoin in Patients With Severe Recalcitrant Nodular Acne |
https://ClinicalTrials.gov/show/NCT00975143 |
Completed |
Cipher Pharmaceuticals Inc. |
2011-05-31 |
| NCT00974870 |
A Pilot Study Testing the Efficacy of a Needling Device for the Treatment of Acne Scars |
https://ClinicalTrials.gov/show/NCT00974870 |
Completed |
Northwestern University |
2010-07-31 |
| NCT00964366 |
Study to Determine and Compare the Tolerance and Irritation Potential of Topical Acne Medications |
https://ClinicalTrials.gov/show/NCT00964366 |
Completed |
GlaxoSmithKline |
2009-08-31 |
| NCT00964223 |
A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne |
https://ClinicalTrials.gov/show/NCT00964223 |
Completed |
GlaxoSmithKline |
2009-11-30 |
| NCT00952523 |
Evaluation of Irritation That Potentially Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face |
https://ClinicalTrials.gov/show/NCT00952523 |
Completed |
Bausch Health Americas, Inc. |
2009-10-31 |
| NCT00933543 |
Efficacy and Safety Study With Visonac Photodynamic Therapy (PDT) |
https://ClinicalTrials.gov/show/NCT00933543 |
Completed |
Photocure |
2010-03-31 |
| NCT00926367 |
Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications |
https://ClinicalTrials.gov/show/NCT00926367 |
Completed |
GlaxoSmithKline |
2009-06-30 |
| NCT00919191 |
Evaluation of Irritation by Two Facial Gels Applied to Opposite Sides of the Face |
https://ClinicalTrials.gov/show/NCT00919191 |
Completed |
Bausch Health Americas, Inc. |
2009-05-31 |
| NCT00913185 |
Comparison Study of Topical Acne Regimens |
https://ClinicalTrials.gov/show/NCT00913185 |
Completed |
MedDerm Associates |
2006-12-31 |
| NCT00907335 |
A Study of Acne Treatment in Children Ages 9 to 11 |
https://ClinicalTrials.gov/show/NCT00907335 |
Completed |
Bausch Health Americas, Inc. |
2009-12-31 |
| NCT00907257 |
A Study of Different Use Regimens Using Two Acne Treatments |
https://ClinicalTrials.gov/show/NCT00907257 |
Completed |
Bausch Health Americas, Inc. |
2009-09-30 |
| NCT00907101 |
Evaluate Effectiveness of Epiduo® Gel in Reducing Antibiotic Sensitive & Resistant Strains of Propionibacterium (P)Acnes |
https://ClinicalTrials.gov/show/NCT00907101 |
Completed |
Galderma Laboratories, L.P. |
2009-07-31 |
| NCT00900939 |
Plant-based Dietary Intervention for Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00900939 |
Completed |
Physicians Committee for Responsible Medicine |
2009-11-30 |
| NCT00891982 |
A Clinical Study to Evaluate the Tolerability of a Topical Antibiotic and Retinoid Used in a Combined Regimen With a BPO Wash |
https://ClinicalTrials.gov/show/NCT00891982 |
Completed |
GlaxoSmithKline |
2009-06-01 |
| NCT00887484 |
A Comparative Study of the Tolerability of Two Combination Therapies for the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00887484 |
Completed |
GlaxoSmithKline |
2009-06-30 |
| NCT00883233 |
Comparison of Four Different Regimens of Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00883233 |
Completed |
Galderma |
2009-09-30 |
| NCT00848744 |
Comparison of Two Salicylic Acid Formulations |
https://ClinicalTrials.gov/show/NCT00848744 |
Completed |
Northwestern University |
2008-08-31 |
| NCT00838812 |
Safety and Efficacy Study of Association Between Tretinoin and Clindamycin on the Treatment of Acne Mild and Moderate |
https://ClinicalTrials.gov/show/NCT00838812 |
Completed |
Igefarma Laboratorios S.A. |
2010-01-31 |
| NCT03752242 |
Evaluation of Topical Application of BMX-010 in Subjects With Acne Vulgaris. |
https://ClinicalTrials.gov/show/NCT03752242 |
Recruiting |
BioMimetix JV, LLC |
2022-09-30 |
| NCT03664752 |
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03664752 |
Recruiting |
Bausch Health Americas, Inc. |
2019-12-31 |
| NCT03664739 |
Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03664739 |
Completed |
Bausch Health Americas, Inc. |
2020-03-23 |
| NCT03524040 |
Imaging of Pilosebaceous Units and Acne Lesions by RCM and OCT Confocal Microscopy and Optical Coherence Tomography |
https://ClinicalTrials.gov/show/NCT03524040 |
Completed |
Bispebjerg Hospital |
2017-12-31 |
| NCT03271021 |
A Study to Evaluate the Efficacy and Safety of Topical Administration of FMX101 in the Treatment of Moderate-to-Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03271021 |
Completed |
Foamix Ltd. |
2018-09-04 |
| NCT00834210 |
Dapsone Gel 5% and Tazarotene Cream 0.1% Versus Tazarotene Cream 0.1% Monotherapy for Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00834210 |
Completed |
Allergan |
2009-09-30 |
| NCT00833183 |
Safety and Efficacy Study of Topical Methyaminlevulinate (MAL) in Subjects With Facial Acne |
https://ClinicalTrials.gov/show/NCT00833183 |
Completed |
Photocure |
2008-07-31 |
| NCT03563365 |
The Functional and Emotional Benefits of Replenix Power of Three With Resveratrol |
https://ClinicalTrials.gov/show/NCT03563365 |
Recruiting |
Yardley Dermatology Associates |
2020-01-04 |
| NCT02216864 |
Effect of Multiple Subcisions on Rolling Acne Scars |
https://ClinicalTrials.gov/show/NCT02216864 |
Active, not recruiting |
Northwestern University |
2020-12-31 |
| NCT00841776 |
Comparative Antimicrobial Efficacy of Two Topical Acne Therapies for the Treatment of Facial Acne |
https://ClinicalTrials.gov/show/NCT00841776 |
Completed |
GlaxoSmithKline |
2008-11-30 |
| NCT01974323 |
Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01974323 |
Completed |
Almirall, S.A. |
2014-10-31 |
| NCT01910064 |
A Long Term Study of GK530G in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01910064 |
Completed |
Galderma R&D |
2014-08-31 |
| NCT01769664 |
A Study Comparing Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel to Duac® Topical Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT01769664 |
Completed |
Taro Pharmaceuticals USA |
2013-06-30 |
| NCT04214652 |
Clinical Study Comparing the Efficacy and Safety of IDP-126 Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT04214652 |
Recruiting |
Bausch Health Americas, Inc. |
2020-07-31 |
| NCT03307577 |
A Phase 2 Safety and Efficacy Study of UHE-101 Cream in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03307577 |
Completed |
Therapeutics, Inc. |
2018-05-31 |
| NCT03292640 |
A Study of the Safety and Efficacy of DFD-03 Lotion in the Treatment of Acne Vulgaris for 12 Weeks |
https://ClinicalTrials.gov/show/NCT03292640 |
Completed |
Dr. Reddy’s Laboratories Limited |
2018-05-14 |
| NCT03132194 |
Study Comparing Test to Aczone 7.5% and Both to a Placebo Control in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT03132194 |
Completed |
Taro Pharmaceuticals USA |
2017-01-16 |
| NCT03071549 |
Combined Salicylic and Azaleic Acid Verus Trichloroacetic Acid 25% Peel in Treatment of Acne |
https://ClinicalTrials.gov/show/NCT03071549 |
Completed |
Cairo University |
2016-08-31 |
| NCT02581072 |
A Thorough ECG Study in Subjects With Acne Vulgaris Treated With SB204 |
https://ClinicalTrials.gov/show/NCT02581072 |
Completed |
Novan, Inc. |
2015-12-31 |
| NCT02413346 |
A Multi-Center Open-Label Evaluation of the Safety of Sarecycline Tablets in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02413346 |
Completed |
Almirall, S.A. |
2016-08-26 |
| NCT03681470 |
Aczone Gel 7.5% in the Treatment of Acne Vulgaris in Patients With Skin of Color |
https://ClinicalTrials.gov/show/NCT03681470 |
Recruiting |
Icahn School of Medicine at Mount Sinai |
2020-12-31 |
| NCT02556788 |
Double-Blind Efficacy and Safety of CD5789 (Trifarotene) 50µg/g Cream Versus Vehicle Cream in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT02556788 |
Completed |
Galderma R&D |
2017-02-07 |
| NCT01657110 |
Pilot Study to Evaluate Tea Tree Oil Gel for Facial Acne |
https://ClinicalTrials.gov/show/NCT01657110 |
Completed |
The University of Western Australia |
2014-12-31 |
| NCT01160848 |
Photoactive Porphyrins (PAP) Levels After Topical Visonac Application in Acne Patients |
https://ClinicalTrials.gov/show/NCT01160848 |
Completed |
Photocure |
2011-01-31 |
| NCT00807014 |
Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00807014 |
Completed |
GlaxoSmithKline |
2008-08-31 |
| NCT00787943 |
Study of Two Different 10.0% Benzoyl Peroxide Creams for Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00787943 |
Completed |
Northwestern University |
2009-01-31 |
| NCT00776919 |
Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT00776919 |
Completed |
GlaxoSmithKline |
2009-09-30 |
| NCT00767104 |
Efficacy of Silk - Like Bedding Fabric Pillow Case in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00767104 |
Completed |
Wake Forest University Health Sciences |
2009-03-31 |
| NCT00757523 |
Evaluation of the Effectiveness, Safety, and Tolerability of Duac Akne Gel and Epiduo Gel in the Treatment of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00757523 |
Completed |
GlaxoSmithKline |
2009-04-24 |
| NCT00752635 |
Comparison of Efficacy and Safety of Norgestimate-ethinyl Estradiol and Cyproterone Acetate-ethinyl Estradiol in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00752635 |
Completed |
Johnson & Johnson Taiwan Ltd |
NA |
| NCT00748462 |
Fractional CO2 Treatment of Acne Scars in Asians |
https://ClinicalTrials.gov/show/NCT00748462 |
Completed |
Mahidol University |
2008-12-31 |
| NCT00725439 |
An Open Label Trial to Assess the Safety and Efficacy of Oral R115866 in the Treatment Facial Acne |
https://ClinicalTrials.gov/show/NCT00725439 |
Completed |
GlaxoSmithKline |
2005-07-31 |
| NCT00722761 |
Safety and Efficacy Of Drospirenone and Ethinyl Estradiol vs Placebo in the Treatment of Truncal Acne |
https://ClinicalTrials.gov/show/NCT00722761 |
Completed |
Massachusetts General Hospital |
2012-04-30 |
| NCT00714714 |
Evaluation of Irritation That Could be Caused by Two Facial Gels Applied to Opposite Sides of the Face. |
https://ClinicalTrials.gov/show/NCT00714714 |
Completed |
Bausch Health Americas, Inc. |
2008-02-29 |
| NCT00714454 |
5% Sodium L-Ascorbyl-2-Phosphate Lotion for the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00714454 |
Completed |
University of Miami |
NA |
| NCT00713609 |
Safety and Efficacy Study of Clindamycin/Benzoyl Peroxide/Tazarotene Cream in Subjects With Acne |
https://ClinicalTrials.gov/show/NCT00713609 |
Completed |
GlaxoSmithKline |
2009-03-31 |
| NCT00706433 |
Light Dose Ranging Study of Photodynamic Therapy (PDT) With Levulan + Blue Light Versus Vehicle + Blue Light in Severe Facial Acne |
https://ClinicalTrials.gov/show/NCT00706433 |
Completed |
DUSA Pharmaceuticals, Inc. |
2008-07-31 |
| NCT00696449 |
Analysis of Adherence in Subjects Undergoing Differin Gel, 0.1% Treatment of Moderate to Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00696449 |
Completed |
Wake Forest University Health Sciences |
2007-05-31 |
| NCT00689117 |
A Clinical Study to Evaluate the Safety and Effectiveness of an Investigational Product Called CT Gel |
https://ClinicalTrials.gov/show/NCT00689117 |
Completed |
GlaxoSmithKline |
2009-04-30 |
| NCT00688064 |
Adapalene-BPO Gel Associated With Doxycycline Hyclate 100 mg in the Treatment of Severe Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00688064 |
Completed |
Galderma |
2009-02-28 |
| NCT00687908 |
Adapalene-Benzoy Peroxide (BPO) Gel in the Treatment of Acne Vulgaris as a 6-month Maintenance |
https://ClinicalTrials.gov/show/NCT00687908 |
Completed |
Galderma |
2009-07-31 |
| NCT00673933 |
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Patients With Skin Type V or IV With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00673933 |
Completed |
Photocure |
2008-12-31 |
| NCT00671749 |
Combination Therapy With Differin® Gel 0.3% and Duac® (Clindamycin/Benzoyl Peroxide Gel) in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00671749 |
Completed |
Galderma Laboratories, L.P. |
2008-08-31 |
| NCT00666900 |
A Clinical Study Evaluating the Safety and Efficacy of IDP-107 in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00666900 |
Completed |
Dow Pharmaceutical Sciences |
2009-03-31 |
| NCT00664248 |
A Clinical Study Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00664248 |
Completed |
Dow Pharmaceutical Sciences |
2007-08-31 |
| NCT00663286 |
A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00663286 |
Completed |
Dow Pharmaceutical Sciences |
2007-08-31 |
| NCT00660985 |
Pharmacokinetic Study to Compare the Systemic Exposure of Differin® Gel, 0.3% or Differin® Gel, 0.1% |
https://ClinicalTrials.gov/show/NCT00660985 |
Completed |
Galderma |
2008-08-31 |
| NCT00656981 |
Evaluate Safety and Efficacy of an Oral Contraceptive (OC) Preparation Versus Placebo for 6 Treatment Cycles in Women With Moderate Acne |
https://ClinicalTrials.gov/show/NCT00656981 |
Completed |
Bayer |
NA |
| NCT00651469 |
Evaluate Safety and Efficacy of an OC Preparation vs Placebo for 6 Treatment Cycles in Women With Moderate Acne. |
https://ClinicalTrials.gov/show/NCT00651469 |
Completed |
Bayer |
NA |
| NCT00635609 |
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate |
https://ClinicalTrials.gov/show/NCT00635609 |
Completed |
Warner Chilcott |
2008-09-30 |
| NCT00624676 |
Efficacy and Tolerance of a Derivative of Salicylic Acid and 5% Benzoyl Peroxide in Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00624676 |
Completed |
Cosmetique Active International |
2006-08-31 |
| NCT00612573 |
Treatment of Moderate to Severe Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00612573 |
Completed |
Warner Chilcott |
2008-11-30 |
| NCT00599521 |
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% |
https://ClinicalTrials.gov/show/NCT00599521 |
Completed |
Galderma |
2008-11-30 |
| NCT00598832 |
Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% |
https://ClinicalTrials.gov/show/NCT00598832 |
Completed |
Galderma |
2008-10-31 |
| NCT00594425 |
Photodynamic Therapy (PDT) With Methyl Aminolevulinate (MAL) Cream in Moderate to Severe Acne |
https://ClinicalTrials.gov/show/NCT00594425 |
Completed |
Photocure |
2008-07-31 |
| NCT00558831 |
Study of Benzoyl Peroxide Cream for Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00558831 |
Completed |
Northwestern University |
2008-01-31 |
| NCT00525499 |
A Phase 2 Study of ASC-J9 Cream in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00525499 |
Completed |
AndroScience Corp |
2008-04-30 |
| NCT00483145 |
Laser-Mediated Photodynamic Therapy of Acne Vulgaris and Rosacea |
https://ClinicalTrials.gov/show/NCT00483145 |
Completed |
Bispebjerg Hospital |
NA |
| NCT00469755 |
Differin® Gel x12 Wks vs Tazorac® Cream x12 Wks vs Differin® x6 Wks Switched to Tazorac® x6 Wks for Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00469755 |
Completed |
Galderma Laboratories, L.P. |
2006-09-30 |
| NCT00446043 |
A Long-Term Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00446043 |
Completed |
Galderma |
NA |
| NCT00441415 |
Efficacy and Safety of Fixed Combination Adapalene 0.1% / Benzoyl Peroxide 2.5% Gel in the Treatment of Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00441415 |
Completed |
Galderma |
2007-10-31 |
| NCT00437151 |
Analysis of Adherence & Associated Factors in Teenagers Undergoing Treatment of Acne Vulgaris With Differin® Gel 0.1% |
https://ClinicalTrials.gov/show/NCT00437151 |
Completed |
Galderma Laboratories, L.P. |
2007-06-30 |
| NCT00422240 |
Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00422240 |
Completed |
Galderma |
NA |
| NCT00421993 |
A Study to Demonstrate the Efficacy and Safety of Adapalene/Benzoyl Peroxide Topical Gel in Subjects With Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00421993 |
Completed |
Galderma |
2007-10-31 |
| NCT00417456 |
The Development and Evaluation of an “E-Visit” Program for the Management of Acne |
https://ClinicalTrials.gov/show/NCT00417456 |
Completed |
Massachusetts General Hospital |
2007-12-31 |
| NCT00377000 |
A Pilot, Multi-Center, Patient Preference Study Comparing Two Clindamycin/Benzoyl Peroxide Gels. |
https://ClinicalTrials.gov/show/NCT00377000 |
Completed |
Sanofi |
NA |
| NCT00361322 |
Efficacy and Safety of a Preparation Containing an Antibiotic and Anti-Inflammatory Agent in Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00361322 |
Completed |
Hadassah Medical Organization |
NA |
| NCT00355485 |
Microdermabrasion for Acne |
https://ClinicalTrials.gov/show/NCT00355485 |
Completed |
University of Michigan |
2007-07-31 |
| NCT00280657 |
Study on Safety and Efficacy of an Oral Contraceptive in Treating Acne Papulopustulosa |
https://ClinicalTrials.gov/show/NCT00280657 |
Completed |
Bayer |
2005-05-31 |
| NCT00243542 |
Phase IV Study to Gather More Information About the Safety of ACZONE Gel, 5% in Treating Subjects With Acne Who Have G6PD Deficiency |
https://ClinicalTrials.gov/show/NCT00243542 |
Completed |
Allergan |
2006-10-31 |
| NCT00219570 |
Dalacin-T Gel Post Approval Study |
https://ClinicalTrials.gov/show/NCT00219570 |
Completed |
Pfizer |
NA |
| NCT00211523 |
Safety and Efficacy of MBI 226 2.5% and 5.0% Topical Acne Solutions in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00211523 |
Completed |
BioWest Therapeutics Inc |
NA |
| NCT00211497 |
Safety and Efficacy of MBI 226 1.25% and 2.5% Topical Acne Solutions in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00211497 |
Completed |
BioWest Therapeutics Inc |
NA |
| NCT00206895 |
Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study |
https://ClinicalTrials.gov/show/NCT00206895 |
Completed |
Bispebjerg Hospital |
NA |
| NCT00160394 |
Comparison of Duac® Gel And Differin® Gel in Mild to Moderate Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00160394 |
Completed |
GlaxoSmithKline |
2005-08-31 |
| NCT00151541 |
A Phase 3 Study to Compare the Safety and Efficacy of 5% Dapsone Topical Gel, (DTG) Twice Daily in Combination With Once Daily Vehicle Control, Adapalene Gel 0.1% or Benzoyl Peroxide Gel 4% |
https://ClinicalTrials.gov/show/NCT00151541 |
Completed |
Allergan |
2005-07-31 |
| NCT00145106 |
Comparison of Tazarotene and Minocycline Therapies for Maintenance of Facial Acne Vulgaris |
https://ClinicalTrials.gov/show/NCT00145106 |
Completed |
KGL, Inc. |
NA |
| NCT00113425 |
Non-cutting Laser Therapy in the Treatment of Acne |
https://ClinicalTrials.gov/show/NCT00113425 |
Completed |
University of Michigan |
2008-11-30 |
| NCT00110643 |
Infrared Non-Cutting Laser Therapy for Acne |
https://ClinicalTrials.gov/show/NCT00110643 |
Completed |
University of Michigan |
NA |
| NCT00837213 |
Comparative Efficacy and Safety of Benzoyl Peroxide Used in Combination With Clindamycin vs. Benzoyl Peroxide Used in Combination With Clindamycin and Doxycycline in the Treatment of Moderate Acne |
https://ClinicalTrials.gov/show/NCT00837213 |
Completed |
GlaxoSmithKline |
2008-08-31 |
| NCT00818519 |
GA YAZ ACNE in China Phase III |
https://ClinicalTrials.gov/show/NCT00818519 |
Completed |
Bayer |
2010-05-31 |
| NCT00795327 |
Injectable POLY-L-Lactic Acid for Treatment of Hill and Valley Acne Scarring |
https://ClinicalTrials.gov/show/NCT00795327 |
Completed |
Bausch Health Americas, Inc. |
2009-09-30 |
| NCT00031096 |
Comparison of Efficacy and Safety of Azelaic Acid 15% Gel With Its Vehicle in Subjects With Mild to Moderate Acne |
https://ClinicalTrials.gov/show/NCT00031096 |
Completed |
LEO Pharma |
2002-07-31 |
| NCT00658112 |
Measuring Adherence in Subjects With Acne Vulgaris in a Clinic Population Subtitle: Topical Benzoyl Peroxide for Acne |
https://ClinicalTrials.gov/show/NCT00658112 |
Completed |
Wake Forest University Health Sciences |
2008-05-31 |